Investor Presentation - Eurazeo Private Equity
ASSETS UNDER MANAGEMENT
In €m
31/12/2020 PF
30/09/2021
VS.
Change (%)
VS.
NAV
3rd party AUM Total AUM
NAV
3rd party AUM Total AUM
LTM
31/12/2020 PF
Private Equity, Eurazeo
4,536
8,465
13,001
5,718
11,520
17,239
57%
33%
Mid-large buyout
2,523
1,226
3,749
3,020
1,572
4,592
43%
22%
Small-mid buyout
570
470
1,040
842
922
1,765
113%
70%
Growth
1,000
845
1,845
1,310
2,084
3,394
111%
84%
Brands
Healthcare
Venture
Private Funds
425
425
515
515
61%
21%
415
415
419
419
n.s.
1%
18
2,472
2,490
27
2,883
2,909
29%
17%
3,038
3,038
5
3,640
3,645
32%
20%
Private Debt
21
4,308
4,329
28
4,912
4,940
22%
14%
Real Assets, Eurazeo
1,020
51
1,071
955
66
1,020
28%
-5%
Rhône¹ (30%)
1,839
1,839
2,295
2,295
33%
25%
MCH Private Equity (25%)
220
220
241
241
18%
9%
Kurma (40%)
132
132
159
159
19%
21%
Total Portfolio
5,577
15,015
20,592
6,701
19,192
25,894
45%
26%
Asset Management²
1,440
1,440
1,572
1,572
52%
9%
Net cash and other items³
-271
-271
-435
-435
n.s.
n.s.
Total
6,746
15,015
21,760
7,838
19,192
27,030
44%
24%
EURAZEO 1 Including Private Equity and Real Assets. 2 Market value for Eurazeo Group, Rhône, MCH, iM Global Partner.
INVESTOR PRESENTATION
35
55View entire presentation